drugset / Trial / NCT02044952
Efficacy and Safety Study of Tripterygium Glycoside in the Treatment of Crohn's Disease for Induction Remission
NaSingle-groupSingle-blindTreatment
Summary
The purpose of this study is to assess the effect and safety of Tripterygium Glycosides in the treatment of Crohn's disease for induction remission and compare the therapeutic effect with patients who received mesalazine.
Timeline
- Start
- 2014-01
- Primary completion
- 2016-05
- Completion
- 2016-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mesalamine | Small molecule | 4 g | Oral |
| Subject | Tripterygium glycosides | Traditional medicine (herbal / TCM) | 2 mg/kg | Oral |